Access for All

Poll results show voters want fighting Alzheimer’s to be a national priority: 92% of voters support the ASAP Act, which would expand Medicare coverage of Alzheimer's blood tests to enable earlier treatment. marketinstitute.org/new-poll-voter…

Early Alzheimer’s detection is key to better outcomes. Polling shows 92% of voters support the ASAP Act to make sure red tape doesn’t stand between patients and the diagnostic tools they need. Learn more about how a focus on Alzheimer’s could swing voters: washingtonexaminer.com/op-eds/4570642…

A new poll confirms voters are deeply concerned that Medicare and insurance barriers are blocking access to FDA-approved Alzheimer’s treatments and FDA-cleared diagnostic tests. Learn more about why voters back reforms to improve access: marketinstitute.org/new-poll-voter…

Patients in rural areas often experience delayed diagnoses and worse outcomes due to gaps in access and infrastructure. Learn more about how expanding telehealth and investing in local care can help every patient receive timely, effective treatment: static1.squarespace.com/static/6842e68…

Rural patients face provider shortages, long travel times, and limited access to specialty care. Too often, they are forced to delay treatment or go without it entirely. Learn more about the issues rural patients face and how policymakers can help: static1.squarespace.com/static/6842e68…

.@CZ’s new blog about an event hosted by @thehill covers insights on our dated healthcare coverage system and the breakthrough blood tests that screen for Alzheimer’s before symptoms appear. Read more: campaign4access.com/news/takeaways…

Alzheimer’s detection breakthroughs are coming rapidly, but the healthcare system is falling behind. @CZ outlines how Congress should remove barriers and expand access to critical screening tools in AFA’s new blog: campaign4access.com/news/takeaways…

Breakthrough blood tests can detect Alzheimer’s early, yet @RealJoeGrogan highlighted how CED limits coverage for these screening tools at @thehill’s recent event. In AFA’s new blog, @CZ explains why access to tools like these is vital. Read here: campaign4access.com/news/takeaways…

Americans are struggling with rising drug costs, and copay accumulators make the problem worse. Billions in assistance aren’t reaching patients in need as large insurance companies prevent them from using cost-sharing programs to afford treatments. contagionlive.com/view/copay-ass…

Patients deserve a healthcare system that protects their access to care. Copay accumulator programs work against this goal by preventing patients from utilizing copay assistance. static1.squarespace.com/static/6842e68…

Copay accumulator programs raise out-of-pocket costs for patients in need of lifesaving medications and treatments. Patients suffer when systemic barriers keep cures out of reach. Read more: contagionlive.com/view/copay-ass…

At the recent @thehill event on early AD detection, former White House official @RealJoeGrogan explained how Coverage with Evidence Development (CED) policies often place valuable Alzheimer’s tests out of patient reach. Learn more: youtube.com/watch?v=d-9Ni-…

At the recent @thehill event, lawmakers and experts underscored that early Alzheimer’s detection is key to better outcomes. Congress must work to pass the ASAP Act to ensure needless policies don’t stand between patients and diagnostic tools. thehill.com/homenews/57963…

Experts and lawmakers at @thehill’s recent event on Alzheimer's detection highlighted the importance of access to diagnostic tools and preventative care. The ASAP Act is needed to ensure patients get earlier access to life-changing AD detection tools. thehill.com/homenews/57963…

Both doctors and patients agree that prior authorization adds stress, delays, and costs without improving patient outcomes. It’s time to focus on solutions that put patient health first. kff.org/from-drew-altm…

A new survey shows prior authorization is the biggest access burden for patients with chronic conditions. Not scheduling appointments, finding providers, or understanding your bill. The writing is on the wall: patients need this policy to go! kff.org/from-drew-altm…

Prior authorization is a cost-management tool for insurers, at the expense of patients’ access. Patients experience hours-long waits for care approval, resulting in delayed treatment or missed doses of necessary medications. Learn more: kff.org/from-drew-altm…

Early detection and treatment are important means of protecting patients. Unnecessary barriers to access put that in jeopardy. @WaysandMeansGOP and @WaysMeansCmte should focus on removing barriers to prevention and innovation waysandmeans.house.gov/event/health-s…

As lawmakers gather for the Ways & Means hearing on kidney health, outdated policies continue to delay care that could prevent serious illness. @WaysandMeansGOP @WaysMeansCmte should prioritize timely access to the right care. waysandmeans.house.gov/event/health-s…

Patients deserve access to preventive tools and innovative treatments without unneeded barriers. @WaysandMeansGOP @WaysMeansCmte must keep unnecessary hurdles top of mind at their hearing on kidney health. waysandmeans.house.gov/event/health-s…